Aurobindo Pharma clarifies on Zentiva deal; Here’s what it said

Aurobindo Pharma said that Advent International entered into a definitive agreement to sell Zentiva to US-based equity firm GTCR.

Leave a Reply

Your email address will not be published. Required fields are marked *